CRBN
- Animals2
Latest
1 paper in 12 monthsJournal of Medicinal Chemistry
Targeted Degradation of Dipeptidyl Peptidase-4 via Proteolysis-Targeting Chimera Technology for Sustained Glycemic Control in Type 2 Diabetes
Experiments in animalsType 2 diabetes
Nature Communications
Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
Experiments in miceSenolytics